Amplified Sciences

About:

Amplified Sciences is a life science diagnostics company focusing on detecting and pre-empting the risks of debilitating diseases.

Website: https://www.amplifiedsciences.com

Twitter/X: AmpSciences

Top Investors: National Science Foundation, National Cancer Institute, XLerateHealth, Golden Seeds, Purdue Foundry

Description:

Amplified Sciences is a molecular diagnostics company unlike other diagnostics companies due to their ultra-sensitive molecular sensing technology with composition of matter IP exclusively licensed from Purdue University. The technology is disease state agnostic, can detect to the single molecule level, scales easily to point of care, and provides a very favorable cost structure for their platform of reagents. The first application – early detection of pancreatic cancer - is an assay that will quickly prove the investment thesis due to large unmet medical need and a favorable reimbursement path. The team has delivered a working prototype and published proof of concept data.

Total Funding Amount:

$7.58M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

West Lafayette, Indiana, United States

Founded Date:

2016-01-01

Contact Email:

contact(AT)amplifiedsci.com

Founders:

Diana Caldwell, Vincent Jo Davisson

Number of Employees:

1-10

Last Funding Date:

2024-07-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai